In a series of 7 webinar this programme will develop a full picture of the C. difficile infection (CDI) reaching from the importance of a healthy gut microbiota, to its detection and testing methods to current and future therapeutic approaches.

Clostridioides difficile infection is the most frequent cause of antibiotic-associated diarrhea in the hospital setting that has increased in severity. This article looks at the risk factors for developing C. difficile-associated disease, the spectrum of manifestations and the impact of the COVID-19 pandemic on the occurrence of C. difficile infection.

As we look back, we can certainly say that 2021 has been a productive year for gut microbiome research. In this last post of the year, we bring you key articles from our blog and studies on major advances in the role of the gut microbiome in maintaining health and helping to manage gut and immune-related diseases. We will also look at the therapeutic potential of probiotics, prebiotics and postbiotics for your clinical practice.

The role of gut microbiota in shaping immune responses has led scientists to explore the modulation of the immune system as a mechanism underlying the health benefits of probiotics. A new systematic review and meta-analysis of 9 randomized clinical trials suggest probiotics may reduce the incidence of respiratory and gastrointestinal tract infections in generally healthy children and adults.

Although the COVID-19 pandemic has shifted the focus of research for scientists worldwide, major breakthroughs in gut microbiome science have been made in 2020. In this last post of the year, we bring you articles from our blog that cover the major advances in the gut microbiome in 2020, from bench to bedside.

The metabolic activity of immune cells is enhanced after a viral infection, such as the one driven by COVID-19. Dietary approaches that support a healthy gut microbiome can benefit the immune system and ensure a good nutritional status that would help the host deal with pathogens.